[Supraventricular tachycardia during pregnancy].

Area of Science:

• Cardiology
• Maternal-Fetal Medicine
• Electrophysiology

Background:

• Increased cardiac output during pregnancy elevates arrhythmia risk in expectant mothers.
• Supraventricular tachycardia (SVT) is a common cause of arrhythmia symptoms in pregnancy, affecting up to one-sixth of cases.
• First-line treatments for SVT in pregnancy include vagal nerve stimulation and adenosine.

Observation:

• A case study involving a pregnant woman in her third trimester experiencing SVT.
• The patient's SVT was refractory to standard treatments like vagal nerve stimulation and pharmacological interventions.
• Cesarean section was performed prior to the intervention.

Findings:

• Electrical cardioversion was successfully administered to the patient post-cesarean section.
• This intervention effectively resolved the supraventricular tachycardia.
• The procedure demonstrated the safety and efficacy of electrical cardioversion in this specific clinical scenario.

Implications:

• Electrical cardioversion represents a viable and safe alternative treatment for refractory SVT in late-stage pregnancy.
• This case expands treatment options for managing cardiac emergencies in pregnant individuals.
• Further research may explore the broader application of cardioversion in managing arrhythmias during pregnancy.